Purchase and Delivery of Pharmaceutical and Medical Products Tender, USA - 32238092

Procurement Summary

Country : USA

Summary : Purchase and Delivery of Pharmaceutical and Medical Products

Deadline : 26 Apr 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 32238092

Document Ref. No. : FY19-077-DRC-024

Competition : ICB

Financier : Department For International Development

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : IMA WORLD HEALTH
Attn: Procurement team 1730 M Street, NW, STE 1100, Washington, DC 20036 Tel: 202.888.6200
USA
Email :procurement@imaworldhealth.org / drcprocurement@imaworldhealth.org
URL :http://www.imaworldhealth.org/

Tender Details

Tenders are invited for Purchase and Delivery of Pharmaceutical and Medical Products in Kinshasa, Democratic Republic of Congo.

Category: Supplies Market
Location: DR Congo - Kinshasa
Closing date: 26-04-2019
Reference: FY19-077-DRC-024

Subject: Urgent Purchase and Delivery of Pharmaceutical and Medical Products in Kinshasa, Democratic Republic of Congo

Urgent purchase and delivery of pharmaceutical and medical products in Kinshasa, Democratic Republic of Congo

WHO WERE ARE

IMA World Health is a global, faith-based nonprofit that helps developing communities overcome their public health challenges. Founded in 1960 as Interchurch Medical Assistance, today's IMA World Health works alongside governments, non-governmental organizations, faith-based and secular agencies to bring the best in science and public health programming to some of the world's most challenging environments. With offices in six countries and more than $100 million in annual revenue, IMA World Health is a vibrant, growing agency working to achieve health, healing and well-being for all.

IMA World Health offers sustainable and efficient solutions to health-related problems that are far too common in the developing world. IMA World health believes all people are children of God and thus deserve to lead healthy and productive lives. The founding members of IMA World Health, Protestant Churches and church-based organizations, chose to be intentionally ecumenical to provide health services and to build healthy communities around the world. We can do more together than alone; that spirit of joint action remains foundational to IMA World Health today.

IMA intends to implement The Support to the Health System in DRC, known locally as Appui au Système de Santé en RDC or ASSR. The program aims to improve access to critical, quality health services and also strengthen the Ministry of Health-s ability to sustain them. Maternal, adolescent, and child health will be improved through strengthening priority interventions such as the treatment of malaria, pneumonia and diarrhea; nutrition; obstetric and neonatal care; family planning and immunization that are delivered through the health system. ASSR supports 50 zones in 4 provinces (Kasai, Kasai Central, Nord Ubangi, and Maniema).

OUR MISSION AND VISION

To build healthier communities by collaborating with key partners to serve vulnerable people. Our vision of health, healing and well-being for all is based on the Christian call to serve one another Please visit our web site (imaworldhealth.org) for additional background information about IMA World Health, including a description of our major program areas and a list of the countries in which we operate.

IMA World Health invites qualified bidders to submit quotes for the procurement and supply of Essential
Medicines to The Democratic Republic of Congo. Bidders are requested to submit an intention to bid as
soon as possible after receiving the RFP.
Any questions pertaining to this RFP must be submitted in writing before the date listed at the first page
of this RFP. Responses to all questions received will be shared with all participating bidders. Otherwise
extended, no questions will be accepted after set deadline.
Quotes MUST be received prior to the closing date of the RFP. No late quotes will be considered.
Questions and Quotes should be submitted to:
procurement@imaworldhealth.org and drcprocurement@imaworldhealth.org
Contents of RFP: • Cover Page • Overview of IMA World Health • RFP Terms • Instructions to Bidder(s) • Detailed list of medicines needed
Below are applicable RFP terms:
Quotation Validity:
Quotation should be valid for 90 (ninety) days from the RFP due date. This includes, but is not limited to,
cost, pricing, terms and conditions, service levels, and all other information. If your firm is awarded the
contract, all information in the RFP and negotiation process is contractually binding. In exceptional
circumstances, prior to expiry of the original offer validity period, IMA World Health may request that the
bidders extend the period of validity for a specified additional period. Bidders agreeing to the request
will not be permitted to modify their offer.
Delivery Location and Terms:
All quotes received must show total freight cost and insurance costs. Please quote freight based on
INCOTERMS CIP Kinshasa International Airport (FIH) for air shipments.
IMA understands that some of the products will need to be shipped by air, so vendors should indicate
those items in their quote.
Notwithstanding any INCOTERM 2010 used in this Purchase Order, the Bidder shall obtain any e x p o r t
licenses required for products being shipped. All products will be consigned to IMA World Health in
Kinshasa, DRC unless otherwise specified. IMA will require a DHL package containing a set of two copies
of all original shipping documents (packing lists, invoices, B/L or AWB, COO, COA and FERI) sent via DHL in
advance of the shipment to the IMA office in Kinshasa, DRC. Products requiring temperature controlled
shipping can be consolidated and shipped together. IMA World Health has the capacity to receive and hold
goods in temperature controlled storage at the port in Kinshasa while clearance is completed.
Insurance

Where the Incoterm defined Prices of the resulting purchase order from this RFP requires the Bidder to
include transit insurance, the Bidder shall provide such insurance which will include institute cargo
clauses covering 110% of the contract value.
Delivery Timeline:
Please quote your best delivery timeline. Delivery for this order will be in two batches. The order must
be delivered ASAP. Delivery dates quoted must be firm and will be considered as major criteria in the
evaluation and award process.
Promised delivery dates MUST be held by the bidder. Bidder will immediately contact IMA WORLD HEALTH
if unable to deliver products by the delivery date offered.
Contract-Purchase Order Award
The Contract OR Purchase order awarded pursuant to this RFP will be on a fixed price, fixed quantity
basis. IMA World Health may award the contract in whole or in part to one or multiple bidders. IMA World
Health reserves the right to make full, partial or no awards after the completion of the RFP process.
Partial quotation:
Partial offers will be considered at IMA-s discretion.
Quality requirements:
All medicines and medical supplies must comply with World Health Organization (WHO) set quality
standards, principles of Good Manufacturing Practices (GMP), Good Storage Practices (GSP) and Good
Distribution Practices (GDP).
We need products that have been authorized by the DRC authorities for the DRC market (they have “une
autorisation de mise sur le marché en RDC”—AMM) and on their list of essential medicines. If something
has changed that the offerors are aware of and feels they need to inform us then they should do so. We
will not seek any waivers.
Manufacturer Quality assurance documentation demonstrating quality must be provided to IMA World
Health. For the purposes of this RFP, the following quality assurance documentation must be provided:
a) Documents of QA, ISO and GMP certification as applicable
b) Product COA test reports if the manufacturer/product is not SRA approved or WHO pre-qualified.
c) Batch numbers and manufacture dates of all products purchased must be provided for tracking
purposes.
d) Certificate of the Pharmaceutical Product (CPP)
Expiry dates:
Remaining shelf life for medicines and medical supplies should be at least 13 - 14 months or 2/3 of the
factory declared time at the time of the goods arrival to country. Please specify shelf life for each item
as applicable.
Required certificates:

All medicines must be escorted with corresponding Certificates:
1. Certificate of Origin
2. Certificate of Analyses
3. Certificate of Good Manufacturing Practice (GMP)
4. Certificate of Pharmaceutical Product (CPP)
Packing/Labeling instruction:
Goods should be packed in durable boxes with weight not exceeding 20 kg per box. Packing must be
suitable for selected transport mode. Protect for weather influence while in transit.
Medicines being supplied are for regional distribution in DRC. Shipping cartons must be labelled according
to the color coding format for each destination region. Each box must be numbered and must contain
detailed packing list (on outside and inside of the box).
The supplier will pack cartons according to the requested quantities. Products quantities for different
regions can be consolidated in shipments as long as each of the cartons is color labelled and clearly
indicates quantities being shipped.
Labels and color format by region:
Labels placed on each box will be have the following colors according to the region.
CAMENE - GREEN
CEDIMET - BLUE
CADIMEK - RED
KINDU - ORANGE
CAMEKIS - WHITE
Please include the following in quotes: number of boxes & sizes, total volume (CBM) & weight (Kg), total
actual weight.
Payment terms:
IMA World Health intends to award a firm fixed-price purchase order or contract as a result of this RFP
with payment terms being net 30 days from delivery and acceptance of the goods ordered at the location
specified. The invoices and payments will be in United States Dollars (USD). 25% of the contract will be
prepaid, 65% will be paid after all product is shipped and all documents are sent to IMA, and final 10%
will be paid upon confirmation of receipt of all products.
Special Instruction:
IMA World Health may require random inspection and sample collection for testing when batch production
is complete. In such instances, IMA-s designated inspection and sampling agent will schedule a batch
inspection and collect samples for testing at an independent test lab. Bidder will only be able to ship
once independent lab test results have been received and approved by IMA World Health.
Terms and Conditi

Documents

 Tender Notice